换一批
换一批AXL is a key regulator of inherent and chemotherapy-induced invasion and predicts a poor clinical outcome in early-stage colon cancer.
第一作者：
Philip D,Dunne
第一单位：
Centre for Cancer Research and Cell Biology, School of Medicine, Dentistry and Biomedical Science, Queen's University Belfast, 97 Lisburn Road, Belfast, BT9 7BL, Northern Ireland, UK.
作者：
主题词
腺癌(Adenocarcinoma);老年人(Aged);抗肿瘤药(Antineoplastic Agents);细胞系, 肿瘤(Cell Line, Tumor);细胞运动(Cell Movement);结直肠肿瘤(Colorectal Neoplasms);疾病恶化(Disease Progression);女(雌)性(Female);氟尿嘧啶(Fluorouracil);基因表达(Gene Expression);人类(Humans);Kaplan-Meiers评估(Kaplan-Meier Estimate);男(雄)性(Male);中年人(Middle Aged);多元分析(Multivariate Analysis);肿瘤侵润(Neoplasm Invasiveness);肿瘤复发, 局部(Neoplasm Recurrence, Local);肿瘤分期(Neoplasm Staging);有机铂化合物(Organoplatinum Compounds);预后(Prognosis);比例危险度模型(Proportional Hazards Models);原癌基因蛋白质类(Proto-Oncogene Proteins);受体蛋白质酪氨酸激酶类(Receptor Protein-Tyrosine Kinases)
DOI
10.1158/1078-0432.CCR-13-1354
PMID
24170546
发布时间
2024-02-10
- 浏览56
Clinical cancer research
164-75页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
